De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Apiam Animal Health Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Apiam Animal Health te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Healthcare winstgroei	25.6%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

Aug 08

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Feb 24

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

Oct 12

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Sep 02

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Feb 28

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

Nov 18

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 12

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

Feb 25

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Feb 08

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 18

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

Dec 28

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

Dec 11

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Nov 24

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Apiam Animal Health onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

ASX:AHX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (AUD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	205	5	14	19	N/A
3/31/2024	204	4	12	19	N/A
12/31/2023	202	3	11	18	N/A
9/30/2023	197	2	10	18	N/A
6/30/2023	192	2	9	17	N/A
3/31/2023	184	4	10	17	N/A
12/31/2022	176	6	12	17	N/A
9/30/2022	166	5	11	16	N/A
6/30/2022	157	5	11	15	N/A
3/31/2022	149	4	9	14	N/A
12/31/2021	140	4	8	13	N/A
9/30/2021	133	5	9	13	N/A
6/30/2021	126	5	9	14	N/A
3/31/2021	125	5	8	12	N/A
12/31/2020	123	5	8	11	N/A
9/30/2020	121	5	7	9	N/A
6/30/2020	118	4	6	8	N/A
3/31/2020	115	4	4	7	N/A
12/31/2019	112	3	3	6	N/A
9/30/2019	112	3	3	5	N/A
6/30/2019	112	3	2	5	N/A
3/31/2019	112	3	2	6	N/A
12/31/2018	112	3	3	7	N/A
9/30/2018	109	3	4	8	N/A
6/30/2018	107	3	4	9	N/A
3/31/2018	105	3	N/A	7	N/A
12/31/2017	103	4	N/A	5	N/A
9/30/2017	100	4	N/A	4	N/A
6/30/2017	98	5	N/A	2	N/A
3/31/2017	94	5	N/A	0	N/A
12/31/2016	90	5	N/A	-2	N/A
9/30/2016	72	3	N/A	-1	N/A
6/30/2016	54	0	N/A	-1	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van AHX boven de spaarquote ( 2.4% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van AHX naar verwachting sneller zal groeien dan de markt Australian

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van AHX naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van AHX naar verwachting sneller zal groeien dan de markt Australian.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van AHX naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van AHX naar verwachting over 3 jaar hoog zal zijn

Apiam Animal Health Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

Price target increased to AU$1.13

Consensus forecasts updated

Consensus forecasts updated

Price target increased to AU$0.85

Recent updates

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

MD & Executive Director recently bought AU$134k worth of stock

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Financial data availability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Price target increased to AU$1.13

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Consensus forecasts updated

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

Consensus forecasts updated

First half 2022 earnings: EPS misses analyst expectations

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Price target increased to AU$0.85

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting

Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Upcoming Dividend of AU$0.012 Per Share

New 90-day high: AU$0.74

Analysts update estimates

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

First half 2021 earnings released: EPS AU$0.022 (vs AU$0.015 in 1H 2020)

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: AU$0.57

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

New 90-day low: AU$0.60

Price target lowered to AU$0.59

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

New 90-day high: AU$0.74

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Crosvet Pty Ltd.